On remestemcel-L, two sides of the same point.
Something I heard SI say yesterday confirms what I have suspected for quite a while, that the EAP (Expanded Access Program) has been ongoing, it would have been rather inhumane to just stop, despite the cost. For the clinicians already supplying it I suspect it might be a fairly smooth transition one day to the next but probably a lot less paperwork for them, no more urgent EAP applications.
Then there is slide 18 of the AGM presentation, something that has been presented more than once. There would be a moderate pool of professionals in some hospitals who have been using remestemcel-L (as it is now known) for many years, up to a decade for some locations. I suspect the responses expressed are based on quite a few years exposure for most.
- Forums
- ASX - By Stock
- MSB
- Ann: Presentation to 2019 Annual General Meeting
Ann: Presentation to 2019 Annual General Meeting, page-2
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B |
Open | High | Low | Value | Volume |
$1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17804 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 230637 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17804 | 1.085 |
11 | 113582 | 1.080 |
9 | 56080 | 1.075 |
15 | 151472 | 1.070 |
5 | 87306 | 1.065 |
Price($) | Vol. | No. |
---|---|---|
1.090 | 230637 | 5 |
1.095 | 19582 | 2 |
1.100 | 118781 | 5 |
1.105 | 10000 | 1 |
1.110 | 53313 | 3 |
Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.09 |
  |
Change
0.015 ( 1.85 %) |
|||
Open | High | Low | Volume | ||
$1.10 | $1.12 | $1.08 | 1937390 | ||
Last updated 15.59pm 03/05/2024 ? |
Featured News
MSB (ASX) Chart |